K Pharma,Inc. (TYO:4896)
Japan · Delayed Price · Currency is JPY 725.00
-22.00 (-2.95%)
May 12, 2026, 3:30 PM JST
K Pharma,Inc. Market Cap
K Pharma,Inc. has a market cap or net worth of 8.67 billion as of May 12, 2026. Its market cap has decreased by -16.87% in one year.
Market Cap
8.67B
Enterprise Value
7.38B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
725.00
Market Cap Chart
Since October 17, 2023, K Pharma,Inc.'s market cap has decreased from 10.95B to 8.67B, a decrease of -20.77%. That is a compound annual growth rate of -8.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 8.42B | 9.90% |
| Dec 30, 2025 | 7.66B | 6.28% |
| Dec 30, 2024 | 7.21B | -13.75% |
| Dec 29, 2023 | 8.36B | -23.67% |
| Oct 17, 2023 | 10.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellSeed | 10.31B |
| Kubota Pharmaceutical Holdings | 10.27B |
| OncoTherapy Science | 9.21B |
| MEDINET | 7.71B |
| Carna Biosciences | 7.64B |
| BrightPath Biotherapeutics | 7.57B |
| Kohjin Bio | 7.57B |
| StemCell Institute | 7.56B |